Wockhardt gets US nod for Zoloft generic
MUMBAI Jan 9 (Reuters) - Drug maker Wockhardt Ltd (WCKH.BO) said on Wednesday it received the U.S. Food and Drug Administration's approval to sell anti-depression drug sertraline hydrochloride tablets in various strengths.
Sertraline is the cheaper version of Pfizer's (PFE.N) Zoloft, which had a total market of $1.1 billion in the United States, Wockhardt said in a statement.
(Reporting by Bharghavi Nagaraju; Editing by Prem Udayabhanu)
((bharghavi.nagaraju@reuters.com; +91 22 6636 9059; Reuters Messaging: bharghavi.nagaraju.reuters.com@reuters.net)) Keywords: WOCKHARDT SERTRALINE
(C) Reuters 2008. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nBOM154605
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters